Cargando…
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia. Management of AF includes rate control, rhythm control if necessary, prevention of thromboembolic events, and treatment of the underlying disease. Rate control is usually achieved by pharmacological suppression of calcium currents or...
Autores principales: | Schweizer, Patrick A, Becker, Rüdiger, Katus, Hugo A, Thomas, Dierk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023273/ https://www.ncbi.nlm.nih.gov/pubmed/21267357 http://dx.doi.org/10.2147/DDDT.S10315 |
Ejemplares similares
-
Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011) -
Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010) -
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
por: Sullivan, Renee M, et al.
Publicado: (2010) -
Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011)